---
# Model Description
This model is fine-tuned from the meta-llama/Llama-3.2-1B base model to enhance its capabilities in generating relevant and accurate responses related to generic medications under the PMBJP scheme. The fine-tuning process included the following hyperparameters:
- Fine Tuning Template: Llama Q&A
- Max Tokens: 512
- LoRA Alpha: 10
- LoRA Rank (r): 128
- Learning rate: 1e-5
- Gradient Accumulation Steps: 2
- Batch Size: 4
- Quantization: None
---
# Model Quantitative Performace
- Training Quantitative Loss: 0.2073 (at final 5200th Step)
---
# Limitations
- Token Limitations: With a max token limit of 512, the model might not handle very long queries or contexts effectively.
- Training Data Limitations: The model’s performance is contingent on the quality and coverage of the fine-tuning dataset, which may affect its generalizability to different contexts or medications not covered in the dataset.
- Potential Biases: As with any model fine-tuned on specific data, there may be biases based on the dataset used for training.
---
# Model Performace Evaluation:
- Evaluation on 1000 Questions based on dataset (to evaluate the finetuned knowledge base)
- Correct Responses: 79.03%
- Incorrect Responses: 20.97%